Heterogeneity in PHLPP expression or post-translational modifications of FKBP51 in different tumor contexts can explain the diverging results reported in the scientific literature regarding the role of FKBP51 in the regulation of Akt phosphorylation. The gene discussed is PHLPP1; the disease is neoplasm.